Goel David E.
- SEC CIK
- 0001548144
In the past year, 2 open-market sale filings worth $49.0M and no purchases.
Current role at each company
- AURA Aura Biosciences, Inc.10% Owneras of May 11, 2026
- ZNTL Zentalis Pharmaceuticals, Inc.10% Owneras of Dec 15, 2025
- CIK 0001962918Director, 10% Owner, Other: See Remarksas of May 23, 2025
- ALMS Alumis Inc.Director, 10% Owner, Other: See Remarksas of May 23, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $49.0M
- 2 filings
- Net
- −$49.0M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Goel David E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AURA Aura Biosciences, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 (view filing)4:16 PM ET | May 7 | 4 days | Matrix Capital Management Company, LP and 1 other10% Owner | SSaleCommon Stock, par value $0.00001 per share (Common Stock) | −6.92M | $5.64 | −$39.0M | −100.0%0 after | |
| Nov 9, 2023 (view filing)4:35 PM ET | Nov 9 | Same day | Matrix Capital Management Company, LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.00001 per share (Common Stock) | +1.56M | $9.00 | +$14.0M | +29.1%6.92M after | |
| Dec 7, 2022 (view filing)4:30 PM ET | Dec 5 | 2 days | Matrix Capital Management Company, LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.00001 per share ("Common Stock") | +1.25M | $12.00 | +$15.0M | +30.4%5.36M after | |
| Nov 4, 2021 (view filing)4:44 PM ET | Nov 2 | 2 days | Matrix Capital Management Company, LP and 1 other10% Owner | PPurchase | +1.78M | $14.00 | +$25.0M | +76.7%4.11M after |
ZNTL Zentalis Pharmaceuticals, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 (view filing)5:24 PM ET | Dec 15 | Same day | Matrix Capital Management Company, LP and 1 other10% Owner | SSaleCommon Stock, par value $0.001 per share | −7.50M | $1.33 | −$9.97M | −53.7%6.46M after | |
| Jun 20, 2023 (view filing)4:30 PM ET | Jun 20 | Same day | Matrix Capital Management Company, LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +4.76M | $22.66 | +$107.9M | +51.7%14.0M after |